XML 184 R104.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities $ 176,394 $ 153,904 $ 138,910
Net cash provided by discontinued operating activities 76 15 574
Net cash provided by (used in) operating activities 176,470 153,919 139,484
Purchases of property and equipment (95,233) (132,592) (194,647)
Sale of management rights and intellectual property 210,000      
Collection of notes receivable 4,480 2,465 4,161
Increase in restricted cash and cash equivalents (5,060)    
Other investing activities 869 1,848 148
Net cash provided by (used in) investing activities - continuing operations 115,056 (128,279) (190,338)
Net cash used in investing activities - discontinued operations       (1,460)
Net cash provided by (used in) investing activities 115,056 (128,279) (191,798)
Net repayments under credit facility (55,000) (100,000)   
Repurchases of senior notes       (26,965)
Deferred financing costs paid (376) (10,074)   
Proceeds from the issuance of common stock 32,722      
Repurchase of Company stock for retirement (185,400)    
Payment of dividend (62,007)      
Proceeds from exercise of stock option and purchase plans 25,336 4,828 26,075
Excess tax benefit from stock-based compensation 6,736      
Other financing activities, net (755) (404) (2,427)
Net cash used in financing activities - continuing operations (238,744) (105,650) (3,317)
Net cash used in financing activities - discontinued operations         
Net cash used in financing activities (238,744) (105,650) (3,317)
Net change in cash and cash equivalents 52,782 (80,010) (55,631)
Cash and cash equivalents - unrestricted, beginning of period 44,388 124,398 180,029
Cash and cash equivalents - unrestricted, end of period 97,170 44,388 124,398
Parent Guarantor [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities 67,789 31,002 (54,296)
Net cash provided by discontinued operating activities       
Net cash provided by (used in) operating activities 67,789 31,002 (54,296)
Purchases of property and equipment (7,362) (6,110) (1,772)
Sale of management rights and intellectual property 20,000    
Collection of notes receivable       
Increase in restricted cash and cash equivalents       
Other investing activities    3  
Net cash provided by (used in) investing activities - continuing operations 12,638 (6,107) (1,772)
Net cash used in investing activities - discontinued operations       
Net cash provided by (used in) investing activities 12,638 (6,107) (1,772)
Net repayments under credit facility 65,000 (100,000)  
Repurchases of senior notes     (26,965)
Deferred financing costs paid (376) (10,074)  
Proceeds from the issuance of common stock 32,722    
Repurchase of Company stock for retirement (185,400)    
Payment of dividend (62,007)    
Proceeds from exercise of stock option and purchase plans 25,336 4,828 26,075
Excess tax benefit from stock-based compensation 6,736    
Other financing activities, net      (1,000)
Net cash used in financing activities - continuing operations (117,989) (105,246) (1,890)
Net cash used in financing activities - discontinued operations       
Net cash used in financing activities (117,989) (105,246) (1,890)
Net change in cash and cash equivalents (37,562) (80,351) (57,958)
Cash and cash equivalents - unrestricted, beginning of period 37,562 117,913 175,871
Cash and cash equivalents - unrestricted, end of period    37,562 117,913
Issuer [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities 120,000      
Net cash provided by discontinued operating activities         
Net cash provided by (used in) operating activities 120,000      
Purchases of property and equipment         
Sale of management rights and intellectual property       
Collection of notes receivable         
Increase in restricted cash and cash equivalents       
Other investing activities         
Net cash provided by (used in) investing activities - continuing operations         
Net cash used in investing activities - discontinued operations         
Net cash provided by (used in) investing activities         
Net repayments under credit facility (120,000)     
Repurchases of senior notes       
Deferred financing costs paid        
Proceeds from the issuance of common stock       
Repurchase of Company stock for retirement       
Payment of dividend       
Proceeds from exercise of stock option and purchase plans         
Excess tax benefit from stock-based compensation       
Other financing activities, net         
Net cash used in financing activities - continuing operations (120,000)      
Net cash used in financing activities - discontinued operations         
Net cash used in financing activities (120,000)      
Net change in cash and cash equivalents         
Cash and cash equivalents - unrestricted, beginning of period         
Cash and cash equivalents - unrestricted, end of period         
Guarantors [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities (490)      
Net cash provided by discontinued operating activities         
Net cash provided by (used in) operating activities (490)      
Purchases of property and equipment (105)      
Sale of management rights and intellectual property       
Collection of notes receivable         
Increase in restricted cash and cash equivalents       
Other investing activities         
Net cash provided by (used in) investing activities - continuing operations (105)      
Net cash used in investing activities - discontinued operations         
Net cash provided by (used in) investing activities (105)      
Net repayments under credit facility        
Repurchases of senior notes       
Deferred financing costs paid        
Proceeds from the issuance of common stock       
Repurchase of Company stock for retirement       
Payment of dividend       
Proceeds from exercise of stock option and purchase plans         
Excess tax benefit from stock-based compensation       
Other financing activities, net         
Net cash used in financing activities - continuing operations         
Net cash used in financing activities - discontinued operations         
Net cash used in financing activities         
Net change in cash and cash equivalents (595)      
Cash and cash equivalents - unrestricted, beginning of period         
Cash and cash equivalents - unrestricted, end of period (595)      
Non-Guarantors [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities (10,905) 122,902 193,206
Net cash provided by discontinued operating activities 76 15 574
Net cash provided by (used in) operating activities (10,829) 122,917 193,780
Purchases of property and equipment (87,766) (126,482) (192,875)
Sale of management rights and intellectual property 190,000    
Collection of notes receivable 4,480 2,465 4,161
Increase in restricted cash and cash equivalents (5,060)    
Other investing activities 869 1,845 148
Net cash provided by (used in) investing activities - continuing operations 102,523 (122,172) (188,566)
Net cash used in investing activities - discontinued operations       (1,460)
Net cash provided by (used in) investing activities 102,523 (122,172) (190,026)
Net repayments under credit facility        
Deferred financing costs paid        
Proceeds from the issuance of common stock       
Repurchase of Company stock for retirement       
Payment of dividend       
Proceeds from exercise of stock option and purchase plans        
Excess tax benefit from stock-based compensation       
Other financing activities, net (755) (404) (1,427)
Net cash used in financing activities - continuing operations (755) (404) (1,427)
Net cash used in financing activities - discontinued operations         
Net cash used in financing activities (755) (404) (1,427)
Net change in cash and cash equivalents 90,939 341 2,327
Cash and cash equivalents - unrestricted, beginning of period 6,826 6,485 4,158
Cash and cash equivalents - unrestricted, end of period 97,765 6,826 6,485
Eliminations [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by (used in) continuing operating activities         
Net cash provided by discontinued operating activities         
Net cash provided by (used in) operating activities         
Purchases of property and equipment         
Sale of management rights and intellectual property       
Collection of notes receivable         
Increase in restricted cash and cash equivalents       
Other investing activities         
Net cash provided by (used in) investing activities - continuing operations         
Net cash used in investing activities - discontinued operations         
Net cash provided by (used in) investing activities         
Net repayments under credit facility        
Repurchases of senior notes       
Deferred financing costs paid        
Proceeds from the issuance of common stock       
Repurchase of Company stock for retirement       
Payment of dividend       
Proceeds from exercise of stock option and purchase plans         
Excess tax benefit from stock-based compensation       
Other financing activities, net         
Net cash used in financing activities - continuing operations         
Net cash used in financing activities - discontinued operations         
Net cash used in financing activities         
Net change in cash and cash equivalents         
Cash and cash equivalents - unrestricted, beginning of period         
Cash and cash equivalents - unrestricted, end of period